07:12 AM EDT, 08/08/2024 (MT Newswires) -- Eli Lilly and Company ( LLY ) reported Q2 non-GAAP earnings Thursday of $3.92 per diluted share, up from $2.11 a year earlier.

Analysts polled by Capital IQ expected $2.76.

Revenue for the quarter ended June 30 was $11.3 billion, compared with $8.31 billion a year earlier.

Analysts surveyed by Capital IQ expected $9.97 billion.

The drug maker increased its full-year 2024 non-GAAP earnings guidance to $16.10 to $16.60 per share, from $13.50 to $14. Analysts polled by Capital IQ expect $13.71.

Lilly also raised its revenue outlook for the year to $45.4 billion to $46.6 billion, from $42.4 billion to $43.6 billion. Analysts surveyed by Capital IQ expect $42.95 billion.

Lilly shares rose by more than 8% in recent premarket activity.

Price: 845.00, Change: +72.86, Percent Change: +9.44